Pharmacy’s battle for provider status reaches crescendo at state, federal level FDA to host public hearing regarding the implementation of GDUFA European Union launches international generic pilot project to share information FDA releases draft guidance on determining exclusivity period for biologics Sterling Drug founder Leonard Astrup dies McKesson ideaShare policy forum focuses on controlled substances, provider status Impax Labs acquires two generic products from Actavis FDA releases policy documents on compounding, including a draft interim guidance and a final guidance Massachusetts introduces new legislation governing compounding pharmacies APhA board members head to Capitol Hill for H.R. 4190 First Previous 35 36 37 38 39 Next Last
